The Lymphatic and Immune Systems
Slide deck, chapter 2627 slidesChapter outline and sourcesPractice questions
-
26.1 From interstitial space to the venous angle
- Initial lymphatics are blind-ended tubes of one-cell-thick endothelium whose overlapping cells act as one-way flaps; collagen filaments anchor them to the tissue.
- Rising interstitial pressure makes the filaments tug the flaps open, so fluid, protein and cells enter but cannot leak back out.
- Flow then runs through valved collecting vessels, nodes, lymph trunks and finally ducts that empty into the junction of the internal jugular and subclavian veins.
- Intestinal lacteals carry dietary fat as milky chyle into the same system; the CNS, bone marrow, bone, teeth and cornea have no lymphatics.
Outcome
- 1Trace lymph from an interstitial initial lymphatic through collecting vessels, nodes and trunks to the venous angle.
-
26.1 Two ducts, unequal territories
- The thoracic duct begins at the cisterna chyli, anterior to the second lumbar vertebra, and is the main duct returning lymph to blood.
- From the cisterna chyli it passes through the aortic hiatus, ascends in the posterior mediastinum right of the oesophagus and inclines left at about the fifth thoracic vertebra.
- It receives lumbar and intestinal trunks, then in the neck the left jugular, subclavian and bronchomediastinal trunks; it empties at the left venous angle.
- So it drains everything below the ribs plus the left head, neck, chest and left upper limb.
- The right lymphatic duct drains only the upper right body (right jugular, subclavian and bronchomediastinal trunks) into the right venous angle.
Outcome
- 2Distinguish the territories drained by the thoracic duct from those drained by the right lymphatic duct.
-
26.1 What moves lymph without a heart
- Capillary filtration leaves about 3 L/day that venous reabsorption cannot recover; OpenStax counts 20 L filtered, 17 L reabsorbed.
- Plasma protein cannot diffuse back into capillaries against its gradient, so lymphatics are the only route that returns it.
- Driving forces are interstitial pressure, rhythmic contraction of collecting-vessel smooth muscle, skeletal-muscle squeeze and the respiratory pump.
- Valves, set close together and giving a beaded look, make every compression push lymph toward the heart; blockage causes protein-rich lymphedema.
Outcome
- 3Explain how interstitial pressure, smooth-muscle pumping, skeletal-muscle action and valves generate and direct lymph flow.
-
26.1 Lymph node architecture and the route through it
- Afferent vessels pierce the capsule and empty into the subcapsular sinus; lymph then percolates past cortex and paracortex to the medullary sinuses and out one efferent vessel.
- Cortex holds B-cell follicles; a germinal centre marks an activated follicle. Paracortex is the T-cell and dendritic-cell zone.
- Medulla has cords of B cells and plasma cells between sinuses lined with macrophages.
- Blood-borne lymphocytes enter through high endothelial venules (tall, plump endothelium) in the paracortex rather than through lymph.
- Related MALT: palatine, pharyngeal and lingual tonsils (Waldeyer ring, with crypts), Peyer patches and the appendix; tonsils lack afferent lymphatics.
Outcome
- 4Describe the cortex, paracortex and medulla of a lymph node and the route of lymph and cells through it.
-
26.1 Spleen: white pulp versus red pulp
- White pulp surrounds a central arteriole: a cuff of T cells (the periarteriolar lymphoid sheath) with B-cell follicles set along it, and a marginal zone at the edge.
- Red pulp is splenic cords (of Billroth) and venous sinusoids full of red cells and macrophages; it filters blood and clears aged red cells.
- On a section, look for a round pale island around a small artery (white pulp) in a sea of red-stained cords (red pulp).
- Blood-borne antigen meets lymphocytes here, since the spleen has no afferent lymphatics.
- Asplenia predisposes to infection by encapsulated organisms such as Streptococcus pneumoniae, Haemophilus and Neisseria.
Outcome
- 5Identify the red pulp, white pulp and periarteriolar lymphoid sheath of the spleen on a section.
-
26.1 Thymus: cortex, medulla, Hassall corpuscles
- A bilobed organ behind the sternum and in front of the great vessels; capsular trabeculae divide it into lobules that involute after puberty.
- Cortex is darkly stained and packed with thymocytes; medulla is paler, with fewer thymocytes and more epithelial cells.
- Hassall (thymic) corpuscles are concentric whorls of flattened keratinising epithelial cells in the medulla; their role is uncertain.
- Thymic epithelium selects T cells: cortical epithelium tests thymocytes for MHC recognition, and medullary antigen-presenting cells remove strongly self-reactive ones.
Outcome
- 6Identify the cortex, medulla and Hassall corpuscles of the thymus and state the role of the thymic epithelium.
-
26.1 Sentinel nodes and staging
- A sentinel node is the first node to receive lymph from a tumour; if it is clear, downstream nodes are usually clear, so full dissection can be spared.
- Breast lymph drains chiefly to axillary nodes (roughly 75-85%), with the inner quadrants also reaching parasternal (internal thoracic) nodes (roughly 15-25%); the upper limb drains to axillary nodes.
- Head and neck drain to submental, submandibular and deep cervical nodes (jugulo-omohyoid node for the tongue); an enlarged left supraclavicular (Virchow) node signals abdominal cancer.
- Nodal involvement raises cancer stage, so node status shapes prognosis and adjuvant treatment.
Outcome
- 7Identify the sentinel nodes of the breast, upper limb and head and neck and relate them to cancer staging.
-
26.2 First-line barriers
- Physical barriers are intact keratinised skin, mucous membranes and ciliary mucus clearance, which block entry or sweep microbes away.
- Chemical barriers include acidic secretions, sebum, lysozyme in tears and saliva, and antimicrobial peptides called defensins.
- Microbiological barrier: commensal flora compete with pathogens for nutrients and sites.
- These act at once and non-specifically, before any cell has to recognise a particular pathogen.
Outcome
- 8Classify the physical, chemical and microbiological barriers that make up the first line of defence.
-
26.2 Pattern-recognition receptors
- PRRs are germline-encoded receptors that detect conserved microbial features and molecules released by damaged cells, so no clonal selection is needed.
- Toll-like receptors sit on the surface or in endosomes: surface TLR4 senses bacterial LPS, while endosomal TLR3 senses viral double-stranded RNA and TLR9 senses unmethylated CpG DNA.
- NOD-like and RIG-I-like receptors sit in the cytosol and sense intracellular bacteria and viral nucleic acid.
- Signalling through NF-kB turns on inflammatory cytokines and interferons; some NLRs assemble inflammasomes that activate caspase-1 and release IL-1 beta.
Outcome
- 9Compare pattern-recognition receptors (TLR, NLR, RLR) by location and ligand.
-
26.2 Three complement pathways, one effector arm
- Classical pathway is triggered when C1 binds antibody on antigen; lectin pathway when mannose-binding lectin binds microbial sugars; alternative when spontaneous C3 hydrolysis lands on a microbe.
- All three produce C3 convertase, which cleaves C3 into C3a and C3b.
- C3b opsonises; C3a and C5a bind mast cells to release histamine, and C5a attracts neutrophils.
- C1 inhibitor deficiency causes hereditary angioedema; deficiency of terminal components predisposes to Neisseria infection.
- C5b recruits C6, C7, C8 and several C9 into the membrane attack complex, which makes pores and lyses the microbe.
Outcome
- 10Distinguish the classical, lectin and alternative complement pathways by trigger and shared effector steps.
-
26.2 Innate effector cells
- Neutrophils arrive first, squeeze out of vessels by chemotaxis and phagocytose; monocytes follow and mature into larger tissue macrophages.
- Macrophages engulf microbes, dead neutrophils and debris, and secrete cytokines that recruit more cells.
- NK cells kill virus-infected and tumour cells by releasing perforin and granzymes, and are boosted by interferons and IL-2.
- Dendritic cells ingest antigen, migrate through lymphatics to nodes and present it to T cells, bridging innate and adaptive immunity.
Outcome
- 11Describe the roles of neutrophils, macrophages, NK cells and dendritic cells in innate defence.
-
26.2 Mediators behind the cardinal signs
- Histamine and prostaglandins dilate arterioles (redness, heat) and raise capillary permeability, so fluid leaves and produces swelling.
- Kinins such as bradykinin act on nerve endings for pain; prostaglandins intensify and prolong the effects of histamine and kinins.
- IL-1 and related cytokines act on the hypothalamus to raise body temperature, and fever strengthens interferon effects.
- Neutrophils stick to the endothelium, squeeze through (emigration) and follow chemotactic gradients, which adds to local swelling and heat.
Outcome
- 12Explain how histamine, prostaglandins, bradykinin and cytokines produce the cardinal signs of inflammation.
-
26.3 MHC class I versus class II
- MHC I is on every nucleated body cell (not red cells); MHC II is on antigen-presenting cells: dendritic cells, macrophages and B cells.
- MHC I shows peptides from inside the cell (usually 8-10 residues, closed groove) to CD8; MHC II shows peptides taken up from outside (usually 13-25 residues, open groove) to CD4.
- Both are also called HLA; unique to each person (except identical twins), so they drive transplant rejection.
- HLA associations exist: HLA-B27 with ankylosing spondylitis; cross-presentation lets dendritic cells load exogenous antigen on MHC I.
- T cells ignore self peptide in MHC but respond to foreign peptide, so MHC lets T cells judge what is inside a cell.
Outcome
- 13Compare MHC class I and class II molecules by structure, cell distribution and the T-cell co-receptor each engages.
-
26.3 Endogenous versus exogenous processing
- Endogenous (cytosolic) antigens, such as viral proteins, are cut into peptides, loaded onto MHC I in the endoplasmic reticulum and displayed on the surface.
- Exogenous antigens are phagocytosed by an APC, digested in the phagosome or endosome and loaded onto MHC II that was made in the ER and packaged in vesicles.
- The two routes dictate responder: MHC I with CD8 cytotoxic cells, MHC II with CD4 helper cells.
- Most cells can run the endogenous pathway; only professional APCs run the exogenous one.
Outcome
- 14Distinguish the endogenous (cytosolic) from the exogenous (endosomal) antigen-processing pathway.
-
26.3 Helper and cytotoxic T cells
- Activated CD4 T cells secrete IL-2 and other cytokines; IL-2 drives proliferation of helper cells, cytotoxic cells, B cells and NK cells.
- Subsets: Th1 (activates macrophages, IFN-gamma), Th2 (helps B cells, IgE and eosinophil responses), Th17 (recruits neutrophils), Tfh (helps germinal-centre B cells), Treg (suppress).
- CD8 cytotoxic T cells recognise antigen on MHC I and kill by perforin and granzymes, which trigger apoptosis.
- HIV infects CD4 cells, so loss of helper cells weakens both cellular and antibody responses.
Outcome
- 15Describe the roles of CD4 helper subsets (Th1, Th2, Th17, Treg, Tfh) and CD8 cytotoxic T cells.
-
26.3 Two signals and anergy
- Signal 1 is the TCR binding peptide-MHC with CD4 or CD8 helping hold the pair together.
- Signal 2 is co-stimulation, for example B7 on the APC engaging CD28 on the T cell; without it the cell is not activated.
- Recognition without co-stimulation produces anergy: a prolonged unresponsive state, so self-antigens met on non-APCs do not provoke attack.
- Inhibitory receptors such as CTLA-4 and PD-1 damp responses, and checkpoint inhibitors block them to free T cells against tumours.
Outcome
- 16Explain why TCR engagement needs co-stimulation (CD28 with B7) and what anergy means.
-
26.3 V(D)J recombination and receptor diversity
- Receptor genes are assembled in developing lymphocytes by cutting and joining a few hundred versions of several small gene segments (V, D, J).
- RAG1 and RAG2 carry out the cut; TdT adds random nucleotides at the joins, adding junctional diversity.
- Pairing of two different chains (heavy with light, alpha with beta) multiplies the combinations.
- In theory V(D)J rearrangement yields more than 10^16 distinct receptors; Tortora counts at least 10^9 epitopes recognised, from a genome of only about 35,000 genes.
Outcome
- 17Outline V(D)J recombination and how it generates receptor diversity.
-
26.3 Clonal selection and expansion
- Each lymphocyte carries a receptor of one specificity, made before antigen exposure.
- Antigen selects only the few cells whose receptors fit; those proliferate into a clone, with co-stimulation and IL-2 as drivers.
- The clone splits into short-lived effector cells and long-lived memory cells that last for decades.
- Memory is the basis of the faster, larger second response and of vaccination.
Outcome
- 18Explain clonal selection and clonal expansion of antigen-specific lymphocytes.
-
26.4 B-cell activation: T-dependent and T-independent
- A naive B cell binds antigen via its surface Ig, internalises it and shows peptide on MHC II to a Tfh cell; CD40 with CD40L and cytokines then drive activation.
- Within a germinal centre, somatic hypermutation alters the V genes, and selection for tighter binding gives affinity maturation.
- Class switching changes the heavy-chain constant region (IgM to IgG, IgA or IgE) while keeping antigen specificity.
- T-independent antigens, such as repeating polysaccharides, cross-link surface Ig and yield mostly IgM with little memory.
- X-linked agammaglobulinaemia (BTK defect) removes B cells; CD40L deficiency causes hyper-IgM syndrome because class switching fails.
Outcome
- 19Describe B-cell activation by T-dependent and T-independent antigens, including class switching and somatic hypermutation.
-
26.4 The five antibody classes
- IgG is a monomer, about 75% of blood antibody (Tortora gives 80%), and the only class to cross the placenta.
- IgM is a pentamer, the first class secreted, and a strong complement activator; monomeric IgM and IgD are the B-cell receptor on naive cells.
- IgA is about 15% of blood antibody (Tortora gives 10-15%) but dominant in secretions (tears, saliva, milk, gut), as a dimer, and guards mucous membranes.
- IgE is under 0.1% of blood antibody; it sits on mast cells and basophils, mediates allergy and defends against parasitic worms.
Outcome
- 20Compare IgG, IgM, IgA, IgE and IgD by structure, location and function.
-
26.4 Fab and Fc: what each end does
- Each antibody has two identical Fab arms (variable regions of heavy and light chains) that bind antigen, and one Fc stem formed by the paired heavy chains.
- Fab alone can neutralise: binding a toxin or virus blocks its attachment to host cells.
- Fc engages Fc receptors on phagocytes (opsonisation) and on NK cells (cell-mediated killing of coated targets).
- Fc also binds C1 to start the classical complement pathway, giving lysis and C3b opsonin deposition.
Outcome
- 21Relate antibody Fab and Fc regions to neutralisation, opsonisation and complement activation.
-
26.4 Germinal-centre outcomes: plasma cell versus memory B cell
- Plasma cells are antibody factories with abundant rough ER; they secrete large amounts of antibody for days to weeks and then die.
- Memory B cells are long-lived, resemble the original clone, circulate and stay dormant until the same antigen returns.
- Because memory cells outnumber the original naive clone, a repeat exposure gives a faster, more potent response.
- Selection in the germinal centre favours higher-affinity clones, so later responses carry class-switched, higher-affinity antibody.
Outcome
- 22Contrast the plasma cell and memory B cell fates of germinal-centre selection.
-
26.5 Primary and secondary responses compared
- Primary: a lag of about 10 days with no detectable antibody, then IgM rises (peak near day 14) and IgG follows, with a modest titre that wanes within weeks.
- Secondary: the lag shrinks to only a few days, then a higher, faster, mainly IgG response that lasts months.
- Secondary antibody has higher affinity, from somatic hypermutation and selection of memory clones.
- Vaccines exploit this, which is why immunisation uses boosters spaced weeks to months apart.
Outcome
- 23Compare the kinetics, dominant isotype and affinity of the primary and secondary antibody responses.
-
26.5 Four types of hypersensitivity
- Type I: IgE bound to mast cells and basophils; allergen causes histamine and other mediator release within minutes (anaphylaxis, hay fever); epinephrine treats anaphylaxis.
- Type II: antibody against cell or matrix antigen: hemolytic anaemia, Goodpasture syndrome, Graves disease; complement lysis as in incompatible transfusion.
- Type III: IgG or IgM immune complexes lodge under vessel endothelium and activate complement (glomerulonephritis, serum sickness, lupus).
- Type IV: T-cell mediated and delayed, usually developing over 48 to 72 hours (tuberculin test, poison ivy); no antibody is involved.
Outcome
- 24Classify type I to IV hypersensitivity by mediator, timing and a clinical example.
-
26.5 Central and peripheral tolerance
- Central tolerance acts in the primary lymphoid organs: self-reactive T cells are deleted in the thymus, and self-reactive immature B cells are deleted or inactivated in the marrow.
- Peripheral tolerance acts after cells leave: anergy (signal 1 without signal 2), suppression by Treg, and B cells receiving no T-cell help.
- Tolerance is the basis of self-recognition; failure lets lymphocytes attack the body and produces autoimmune disease.
- Failures: APECED (AIRE mutation, thymic negative selection defect), IPEX (FOXP3 mutation, no Treg), Graves disease and lupus.
Outcome
- 25Distinguish central from peripheral tolerance and give a mechanism for each.
-
26.5 Hyperacute, acute and chronic rejection
- MHC (HLA) mismatch is the reason grafts are rejected, because the host sees donor MHC as foreign.
- Hyperacute: preformed antibody against donor antigens (ABO or HLA) triggers complement and vascular thrombosis immediately after reperfusion.
- Acute: host T cells attack the graft via donor MHC, mostly early (heart-graft incidence peaks near 1 month, levels off by 1 year); immunosuppression can reverse it.
- Chronic: slow vascular fibrosis and graft loss over years; the converse problem, graft-versus-host disease, occurs when donor T cells attack the host.
Outcome
- 26Compare hyperacute, acute and chronic transplant rejection.
-
26.5 Primary versus acquired immunodeficiency
- Primary immunodeficiencies are inherited gene defects: SCID affects both T and B arms and children die of opportunistic infection without treatment.
- DiGeorge syndrome (thymic aplasia) leaves T cells low; complement deficiency is another primary defect.
- Acquired immunodeficiencies arise from infection, drugs or disease; HIV is the model.
- HIV uses CD4 as its receptor, so helper T cells decline until opportunistic disease appears.
- AIDS is diagnosed at a helper T cell count below 200 cells per microliter, or earlier on an opportunistic infection.
Outcome
- 27Differentiate primary immunodeficiencies from acquired ones.